Pulmatrix logo

Pulmatrix Share Price (NASDAQ: PULM)

$4.9

-0.07

(-1.41%)

Live

Last updated on

Check the interactive Pulmatrix Stock chart to analyse performance

Pulmatrix Inc Key Stats

Check Pulmatrix key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.97
Open
$4.52
Market Capitalization
$17.9M
Today's Volume
$25.7K
Revenue TTM
$369.0K
EBITDA
$-8.0M
Earnings Per Share (EPS)
$-2.17
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-83.85%

Stock Returns calculator for Pulmatrix Stock including INR - Dollar returns

The Pulmatrix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pulmatrix investment value today

Current value as on today

₹2,49,527

Returns

₹1,49,527

(+149.53%)

Returns from Pulmatrix Stock

₹1,45,000 (+145%)

Dollar Returns*

₹4,527 (+4.53%)

Indian investors sentiment towards Pulmatrix Stock

20%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Pulmatrix Stock from India on INDmoney has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pulmatrix Inc

  • Name

    Holdings %

  • Renaissance Technologies Corp

    2.98%

  • BlackRock Inc

    1.50%

  • SBI Securities Co Ltd

    1.43%

  • Vanguard Group Inc

    1.29%

  • Geode Capital Management, LLC

    1.11%

  • State Street Corp

    0.38%

Analyst Recommendation on Pulmatrix Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Pulmatrix(by analysts ranked 0 to 5 stars)

Pulmatrix Share Price Target

What analysts predicted

Upside of 104.08%

Target:

$10.00

Current:

$4.90

Pulmatrix share price target is $10.00, a slight Upside of 104.08% compared to current price of $4.90 as per analysts' prediction.

Pulmatrix Stock Insights

  • Price Movement

    In the last 3 months, PULM stock has moved down by -28.2%
  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 5.88M → 3.0K (in $), with an average decrease of 83.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 5 quarters, -5.81M → -1.54M (in $), with an average increase of 45.4% per quarter
  • PULM vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 110.3% return, outperforming this stock by 105.4%

Pulmatrix Technicals Summary

Sell

Neutral

Buy

Pulmatrix is currently in a neutral trading position according to technical analysis indicators.

Pulmatrix Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Pulmatrix Inc logo
-7.09%
-40.94%
144.5%
8.43%
-77.97%
Regeneron Pharmaceuticals, Inc. logo
2.56%
-20.81%
-52.23%
-3.35%
-6.84%
Beone Medicines Ltd logo
5.47%
19.61%
55.92%
85.67%
27.02%
Vertex Pharmaceuticals Incorporated logo
-15.59%
-19.02%
-19.41%
38.13%
41.78%
Alnylam Pharmaceuticals, Inc. logo
36.58%
80.91%
64.82%
112.22%
233.41%

About Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
Organization
Pulmatrix
Employees
2
CEO
Mr. Peter Ludlum CMA, MBA
Industry
Health Technology

Key Management of Pulmatrix Inc

NameTitle
Mr. Peter Ludlum CMA, MBA
Interim CEO & Interim CFO
Dr. Alexander M. Klibanov Ph.D.
Founder

Important FAQs about investing in PULM Stock from India :

What is Pulmatrix share price today?

Pulmatrix share price today is $4.90 as on . Pulmatrix share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Pulmatrix share?

Pulmatrix share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Pulmatrix stock price today i.e. is trending at $4.90, lower by 52.88% versus the 52 week high.

How to invest in Pulmatrix Stock (PULM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pulmatrix on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmatrix Shares that will get you 0.3061 shares as per Pulmatrix share price of $4.90 per share as on August 26, 2025 at 9:36 PM IST.

What is the minimum amount required to buy Pulmatrix Stock (PULM) from India?

Indian investors can start investing in Pulmatrix (PULM) shares with as little as ₹87.6525 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Pulmatrix stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Pulmatrix share’s latest price of $4.90 as on August 26, 2025 at 9:36 PM IST, you will get 2.0408 shares of Pulmatrix. Learn more about fractional shares .

What are the returns that Pulmatrix has given to Indian investors in the last 5 years?

Pulmatrix stock has given -77.97% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?